Esco Global Strategies
Medical Device Manufacturing in the Dominican Republic: Free Zone and CAFTA-DR Guide
How foreign medical device manufacturers establish DR free zone operations and access the US market duty-free under CAFTA-DR.
What is medical device manufacturing in the Dominican Republic?
Medical device manufacturing in the Dominican Republic allows companies to produce FDA-proximate devices in free zones with 0% corporate tax under Law 8-90 and export duty-free to the United States under CAFTA-DR. DR free zones offer GMP-ready facilities, competitive labor costs, and 2–4 day shipping to U.S. East Coast ports.
Executive Summary
The Dominican Republic offers foreign medical device manufacturers a direct path to the US market. Two frameworks drive this advantage: Law 8-90 free zone incentives and the CAFTA-DR trade agreement, in force since March 1, 2007. Under Law 8-90, free zone operators pay 0% corporate income tax for a minimum of 15 years, 0% import duties on inputs, and 0% export taxes. Qualifying medical devices under HS Chapter 90 enter the US duty-free under CAFTA-DR. Sea freight transit to US East Coast ports is approximately 2–4 days — a structural logistics edge over Asian alternatives.
The Short Answer
Medical device manufacturers in Dominican Republic free zones get three compounding advantages: zero corporate tax, duty-free US market access, and fast logistics. Together, these reduce total landed cost in ways that no single factor achieves alone.
- 0% corporate tax under Law 8-90 for a minimum of 15 years — no reinvestment conditions required
- Duty-free US entry for HS Chapter 90 devices under CAFTA-DR (in force March 1, 2007), provided rules of origin are met
- Approximately 2–4 days sea freight to US East Coast ports — faster than any Asian manufacturing hub
Market Overview
The Dominican Republic operates one of the Caribbean Basin’s most developed export manufacturing ecosystems. More than 700 companies operate across 60+ CNZFE-licensed industrial parks. The country’s GDP is approximately USD 120 billion, sustained largely by export-led manufacturing and services.
Medical device and health technology manufacturing has grown as a distinct segment within this system. Proximity to the US healthcare supply chain and alignment with FDA regulatory expectations have made the DR a credible option for precision assembly and regulated product manufacturing. ProDominicana has designated medical devices as a priority FDI sector.
Why the Dominican Republic for Medical Devices
Logistics Position
The Dominican Republic sits in the Caribbean Basin, approximately 2–4 days by sea freight from US East Coast ports. The Caucedo Multimodal Port connects directly to major US logistics hubs. For FDA-regulated inventory with lot traceability requirements, this transit window allows responsive replenishment cycles that Asian sourcing cannot match.
Tax Incentive Framework
Law 8-90 governs the free zone regime. Under this law, operators receive a 0% corporate income tax rate for a minimum of 15 years, extendable to 20 years depending on classification. Import duties on raw materials, components, and capital equipment are 0% inside the free zone perimeter. Export taxes are also 0%.
Trade Agreement Access
CAFTA-DR entered into force for the Dominican Republic on March 1, 2007. Medical devices classified under HS Chapter 90 generally qualify for duty-free US entry — provided rules of origin requirements are satisfied. This eliminates the tariff burden non-CAFTA manufacturers absorb on every shipment to the US market.
Labor Considerations
The Dominican Republic’s workforce is cost-competitive within the Western Hemisphere for assembly and light manufacturing. The combination of trade access, tax neutrality, and logistics proximity reframes the total cost calculus for US-bound manufacturers.
CAFTA-DR Advantage for Medical Device Exporters
CAFTA-DR’s most commercially significant provision is the elimination of US import duties on qualifying HS Chapter 90 goods. Duty-free treatment requires meeting specific rules of origin.
Rules of Origin
To qualify, medical devices must contain at least 35% regional value content under the build-up method, or 45% under the build-down method. Manufacturers sourcing inputs within the CAFTA-DR region, or applying sufficient transformation in a Dominican free zone, will generally satisfy these thresholds.
vs. Non-CAFTA Competitors
Manufacturers outside CAFTA-DR face MFN tariff rates on US imports of HS Chapter 90 goods. Over high-volume, multi-year production runs, this tariff differential compounds into a material structural cost advantage for DR-based operators.
Cost Structure: Dominican Republic vs. Competing Jurisdictions
| Cost Factor | Dominican Republic | Others |
|---|---|---|
| Corporate Tax | 0% under Law 8-90 (minimum 15 years) | Varies by program; not universally 0% |
| US Market Access | Duty-free under CAFTA-DR (HS Ch. 90; in force March 1, 2007) | Vietnam: no US FTA (MFN rates apply). Mexico/Costa Rica: comparable FTA access with varying program conditions |
| Logistics to US East Coast | Approximately 2–4 days sea freight | Asia: significantly longer transit. Mexico: road/sea options available |
| Import Duties on Inputs | 0% on raw materials and capital equipment under Law 8-90 | Duty deferral or exemption available in some markets; structure varies |
Regulatory Framework
CNZFE Licensing
Foreign manufacturers must obtain a CNZFE operating license before commencing operations. The process typically takes 45–90 days from submission of a complete application. Timeline depends on documentation completeness, operation complexity, and the industrial park selected.
US FDA Compliance
Dominican regulatory approvals do not substitute for US FDA obligations. Manufacturers exporting to the US must satisfy FDA registration requirements, Quality System Regulations under 21 CFR Part 820, and device-specific classification rules. ISO 13485 certification is widely adopted alongside these requirements.
ProDominicana Support
ProDominicana provides investor facilitation services covering CNZFE application navigation, industrial park selection, and sector ministry coordination. Engaging ProDominicana early reduces administrative friction and clarifies compliance timelines.
Strategic Considerations by Origin Market
US-Based Manufacturers
US companies evaluating nearshore production will find the DR’s CAFTA-DR qualification and 2–4 day transit time enables a responsive, tariff-free supply chain. The 0% corporate tax for a minimum of 15 years provides fiscal visibility that supports capital investment planning.
Middle East and UAE Companies
GCC-based manufacturers seeking US market access for medical devices can use the Dominican Republic as a structured re-export platform when CAFTA-DR rules of origin are satisfied through sufficient transformation within the free zone. Currency operations are typically conducted in USD.
Israeli Medtech Companies
Israeli medical device companies have historically used third-country manufacturing to optimize US market entry. The DR’s free zone framework, combined with CAFTA-DR access, provides a compliant and cost-structured path to FDA-registered US distribution.
Frequently Asked Questions
What corporate tax rate applies in a Dominican Republic free zone?
Under Law 8-90, free zone operators pay 0% corporate income tax for a minimum of 15 years, extendable to 20 years. This applies to all income from free zone activities with no reinvestment conditions beyond standard operating compliance.
Do Dominican-made medical devices qualify for duty-free US entry under CAFTA-DR?
HS Chapter 90 medical devices generally qualify for duty-free treatment under CAFTA-DR (in force March 1, 2007). Goods must satisfy rules of origin — 35% regional value content (build-up) or 45% (build-down). Manufacturers must document origin compliance for US Customs verification.
How long does CNZFE licensing take?
Typically 45–90 days from submission of a complete application. Timeline variability is driven by documentation completeness and operation complexity. Legal counsel with CNZFE experience reduces errors that extend timelines.
Does the DR have adequate infrastructure for medical device manufacturing?
The Dominican Republic operates 60+ CNZFE-licensed industrial parks with 700+ companies. Manufacturers should conduct site-specific due diligence on utility reliability, clean room feasibility, and proximity to the Caucedo Multimodal Port.
What FDA obligations apply to DR free zone manufacturers exporting to the US?
Dominican approvals do not substitute for FDA compliance. Exporters must satisfy FDA registration, 21 CFR Part 820 Quality System Regulations, and device classification requirements. FDA obligations are determined by device classification and intended use — not manufacturing jurisdiction.
How Esco Global Strategies Supports Medical Device Market Entry
Esco Global Strategies advises medical device manufacturers on structuring CNZFE-compliant free zone operations, coordinating CAFTA-DR rules of origin analysis, and aligning investment structures with Law 8-90. EGS operates across the Caribbean Economic Corridor — connecting the Middle East, Dominican Republic, and United States. Contact EGS at contact@escoglobalstrategies.com.
Related Intelligence
Next Step
Ready to Explore the Caribbean Economic Corridor?
Not sure if your company qualifies? Take the 5-minute assessment. Ready to speak with a strategist? Contact us directly.
Continue Your Research
Complete Guide: Manufacturing in the Dominican Republic – Everything foreign manufacturers need to know about production in DR free zones.
How to Set Up Your DR Free Zone Company – Step-by-step company formation, licensing, and compliance.